Liver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyPathologyCell TransplantationTransplantation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicTreatment OutcomeLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationRetrospective StudiesTissue and Organ ProcurementTransplantation ToleranceTime FactorsPeripheral Blood Stem Cell TransplantationLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationPathology, ClinicalRecurrenceWaiting ListsPathology, SurgicalTransplantation, HeterologousMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilityHematologic NeoplasmsFollow-Up StudiesTacrolimusTissue TransplantationCyclosporineWhole-Body IrradiationCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationLiver DiseasesFacial TransplantationDonor SelectionOrgan PreservationMice, Inbred C57BLBusulfanDisease Models, AnimalTransplantsKidney Failure, ChronicRisk FactorsHLA AntigensLeukemiaCombined Modality TherapyBronchiolitis ObliteransAcute DiseaseLiverPrognosisAntilymphocyte SerumCytomegalovirus InfectionsBiopsyRemission InductionAnemia, AplasticPostoperative PeriodHand TransplantationRats, Inbred LewBlood Group IncompatibilityMycophenolic AcidMyeloablative AgonistsHematopoietic Stem CellsProspective StudiesTissue and Organ HarvestingCyclophosphamidePatient SelectionEnd Stage Liver DiseaseDisease-Free SurvivalNeoplasm TransplantationT-LymphocytesCell DifferentiationBrain DeathLiver Failure, AcuteLiver CirrhosisMelphalan